Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acsmedchemlett.6c00089
文献链接: https://pubs.acs.org/doi/10.1021/acsmedchemlett.6c00089
其他信息:
出版社: American Chemical Society (ACS)
作者: Christine M. Tarby; Amy Hart; Honghe Wan; Liqi He; John Tokarski; Brian Fink; Yufen Zhao; Tram Huynh; Ashvinikumar Gavai; Kurt Zimmermann; Gregory Vite; Dolatrai Vyas; Jennifer Inghrim; Mary Obermeier; Aberra Fura; Paul Elzinga; John Hunt; Urvashi Roongta; Benjamin Henley; Jonathan Lippy; Arvind Mathur; Dauh Rurng Wu; Peng Li; Nirmala Raghavan; Gerry Everlof; Brent Rupnow; Francis Lee; Joseph Fargnoli; Jeffrey Tredup; Susan E. Kiefer; Deepa Calambur; Anuradha Gupta; Muthalagu Vetrichelvan; Murugaiah A. M. Subbaiah; Ashok V. Purandare
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.6c00089
